单用利妥昔单抗有效治疗微小病变肾病1例

李双喜; 李娟; 边琪; 董睿; 孙婧; 郭志勇; 许静

doi:10.3969/j.issn.1671-2390.2023.01.015

李双喜, 李娟, 边琪, 董睿, 孙婧, 郭志勇, 许静. 单用利妥昔单抗有效治疗微小病变肾病1例[J]. 临床肾脏病杂志, 2023, 23(1): 82-85. DOI: 10.3969/j.issn.1671-2390.2023.01.015

引用本文:

李双喜, 李娟, 边琪, 董睿, 孙婧, 郭志勇, 许静. 单用利妥昔单抗有效治疗微小病变肾病1例[J]. 临床肾脏病杂志, 2023, 23(1): 82-85. DOI: 10.3969/j.issn.1671-2390.2023.01.015

Li Shuang-xi, Li Juan, Bian Qi, Dong Rui, Sun Jing, Guo Zhi-yong, Xu Jing. Rituximab as a front-line therapy for minimal change disease: one case report[J]. Journal of Clinical Nephrology, 2023, 23(1): 82-85. DOI: 10.3969/j.issn.1671-2390.2023.01.015

Citation:

Li Shuang-xi, Li Juan, Bian Qi, Dong Rui, Sun Jing, Guo Zhi-yong, Xu Jing. Rituximab as a front-line therapy for minimal change disease: one case report[J]. Journal of Clinical Nephrology, 2023, 23(1): 82-85. DOI: 10.3969/j.issn.1671-2390.2023.01.015

单用利妥昔单抗有效治疗微小病变肾病1例

Rituximab as a front-line therapy for minimal change disease: one case report

摘要

HTML全文

参考文献(22)

资源附件(0)

/